Novartis India Ltd (NOVARTIND) — Board Meeting | 2 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
78th AGM scheduled for September 24, 2026 via video conferencing with key director appointments and resolution votes.
🔄 What Changed
Appointment of four new directors and approval of ESOP 2026; no prior filings indicate these changes were previously disclosed.
🔮 What's Next
None provided in the document.
💡 Investor Takeaway
Shareholders will decide on critical governance changes including new director appointments and ESOP implementation following the change in control.

The 78th Annual General Meeting of Novartis India Ltd is scheduled for September 24, 2026 via video conferencing. Shareholders will vote on key resolutions including adoption of FY2025-26 financial statements, appointment of four new directors (Ashok Bhatia, Kshitij Sheth, Dr. Jagriti Gupta, Ramesh Ramadurai), approval of the Employee Stock Option Scheme 2026, and a proposed name change to Evonile Pharma Limited. The meeting follows the sale of 70.68% stake by Novartis AG to WaveRise, ChrysCapital Fund X, and Two Infinity Partners effective July 29, 2026, ending its promoter status. Remuneration details for directors and ESOP terms are also on the agenda.

📄 View Original Announcement (PDF)

About Novartis India Ltd (NOVARTIND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹5,908.88 Cr P/E: 60.4 ROE: 11.9% ROCE: 16.7%

View full NOVARTIND stock details →

📡 Get AI alerts when NOVARTIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NOVARTIND — Free

📊 More NOVARTIND filings

See all NOVARTIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NOVARTIND files new disclosures

Track NOVARTIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NOVARTIND — Free

Free account · 2 AI queries/day